Entities / Company
sobi.
German beverage store chain
- Reports this week
- 0
- Active events
- 0
- Connections
- 8
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Gone quiet
No new reports in 90+ days-
Apellis is acquired by Biogen, and Aspaveli receives approval in the European Union.Some support2 reports
-
Apellis Pharmaceuticals secured a royalty purchase agreement with Sobi, while also awaiting FDA regulatory decisions, amid AI stock trends benefiting from tariffs.Speculative2 reports
-
Apellis Pharmaceuticals and Sobi reached a capped royalty purchase agreement following FDA approval of EMPAVELI.Some support5 reports
No events began in the chosen period. Widen it, or reset.
Connections
The 2 strongest of 8, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Apellis Pharmaceuticals (United States) Transactional
Sobi acquired 90% of Apellis' ex-U.S. royalties, establishing a financial agreement and joint development rights.
-
Biogen Mentioned together
No evidence was provided describing a relationship between Biogen and sobi.
History
Events by the month they beganJune 2026
3 events- Apellis is acquired by Biogen, and Aspaveli receives approval in the European Union.
- Apellis Pharmaceuticals secured a royalty purchase agreement with Sobi, while also awaiting FDA regulatory decisions, amid AI stock trends benefiting from tariffs.
- Apellis Pharmaceuticals and Sobi reached a capped royalty purchase agreement following FDA approval of EMPAVELI.